A bill to establish a statutory independent regulator for biotech sector covering research, transport, import, manufacture and use of organisms and products of modern biotechnology was introduced in the Lok Sabha on Monday.
There will be a huge market for healthcare professionals, data and security experts and digital marketers, says Navneet Singh, founder, Avsar HR Services.
Dr B Ashok, an IAS officer from Kerala, explains why he wrote a controversial article supporting the invite to Narendra Modi by a mutt in the state.
Bureaucratic delays are stifling growth in the sector. India should be far more aggressive in launching 'look alike' biological molecules in a fast track manner.
Political leaders cutting across party lines have joined hands with the civil society to launch a nationwide campaign against GM crops and the Biotechnology Regulatory Authority of India Bill.
President A P J Abdul Kalam on Saturday said the country needed a national biotech policy for tapping the full potential of the science and utilising it for economic development.
Government on Friday said it was eyeing the biotechnology sector as a major thrust area and would improve regulatory mechanisms for rational promotion of genetically-modified organisms.
The announcement comes as a big relief to international students, including those from India.
Bhargava is a pioneer in the field of biotechnology in the country.
There are a number of vaccine candidates already in clinical trial and a few out of those candidates have completed phase 1/2 status, he said, adding that there are trials that will be going into phase three sometime at the end of July and then others will follow in the months of August, September and October.
Over the last four days, the Indian arm of US pharmaceutical giant Pfizer, Pune-based Serum Institute of India and Hyderabad-based pharmaceutical firm Bharat Biotech have applied to the Drugs Controller General of India seeking emergency use authorisation for their COVID-19 vaccines.
Shrot Katewa from Jhunjhunu district of Rajasthan started 'Source for Change'- a rural BPO to empower the women of his village through professional training activities leading to employment. This is his story.
India's biotech sector is expected to grow 25-30 per cent during the current fiscal over Rs 1,830 crore revenue generated during 2002-03, according to a joint survey by the Association of Biotechnology Led Enterprises and Biospectrum.
Scientists at the Kashmir Agriculture University have produced the world's first cloned Pashmina goat.
Communications between the USTR and the world's most powerful pharmaceutical and trade lobbying groups reveal that many raised concerns about India's push to exempt Covid vaccines from intellectual property.
Apply for the Stanford-India Biodesign Fellowship in Biomedical Technology Innovation or the S K Patil Loan Scholarships to study abroad. Read on for details
Scientists at the Kashmir Agriculture University have produced the world's first cloned pashmina goat.
Since the trial participants were not exposed to the coronavirus after vaccination, the scientists said it is not possible for the current study to determine the efficacy of the candidate vaccine.
We have to be much more rigorous and analytical in assessing the importance of the BRICS, says Parag Khanna.
Biotech company denies all charges.
Almost each of these companies has a different technology to show for the effectiveness against microbes.
Najeeb Ahmad, pursuing MSc in Biotechnology and resident of room 106 of Mahi/Mandavi hostel, has been missing since yesterday allegedly after an altercation with a few students on Saturday night, they added.
Eminent Indian-origin academician Srikant Datar has been named as Dean of Harvard Business School, succeeding Nitin Nohria and becoming the second consecutive dean hailing from India to lead the prestigious 112-year-old institution. Datar, an alumnus of University of Bombay and Indian Institute of Management, Ahmedabad, is the Arthur Lowes Dickinson Professor of Business Administration and the senior associate dean for University Affairs at Harvard Business School (HBS). He will assume charge as the school's next dean on January 1, president Larry Bacow said.
Pfizer and BioNTech said they have concluded phase 3 study of their mRNA-based COVID-19 vaccine candidate BNT162b2, meeting all primary efficacy endpoints.
Can Interferon alfa-2b treat COVID-19 effectively?
Their exceptional technical contributions hold great promise to shape our future.
Prime Minister Narendra Modi and his Belgian counterpart Charles Michel remotely launched Asia's biggest telescope, the ARIES, built with Belgian assistance.
Vardhan stated the government is taking full precautions in human trials of vaccines and the National Expert Group on Vaccine Administration for COVID-19 under the chairmanship of Dr V K Paul, member-health, NITI Aayog, is drawing up a detailed strategy on how to immunize the majority of the population.
The Bengaluru-headquartered firm had posted a net profit of Rs 84.85 crore (Rs 848.5 million) during the same period of previous fiscal.
From MBBS to biotechnology, across academic and professional programmes, the regulators have consistently been betraying the trust students place in them. Read on to find out how.
The CBSE has mounted 32 sample papers of Class XII and of 28 other examinations on its website and students can download them free.
US-based drugmaker Pfizer and Indian biotechnology major Bicon today said they have agreed to end their alliance to sell insulin and insulin analog products made by the Indian company.
'If the trial succeeds, it will become the success of Ayurveda.' 'If it's a failure, it's my failure alone.'
Think beyond engineering and medicine.
There were apprehensions in the SII about rival Bharat Biotech's 'indigenous' tag, opening up shortcuts for it. One senior person, who was very familiar with the sector, told me, 'The message has gone out from the very top. Somani (V G Somani -- drug controller general of India) has told me "Bharat ka karna hai".' A fascinating excerpt from Abantika Ghosh's Billions Under Lockdown: The Inside Story Of India's Fight Against COVID-19.
Scientists around the world, including in India, suggest it hasn't been tested properly given the time constraint and there may not be enough evidence to prove its efficacy.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances